Advertisement

Topics

CytoReason Company Profile

12:01 EDT 14th August 2018 | BioPortfolio

Born out of 10 years’ research from Stanford and the Technion, CytoReason is the only AI company to focus entirely on the immune system in developing its proprietary data and AI / machine-learning approach. This approach is capable of constructing 3-dimensional maps of previously hidden, immune-system relationships at a cellular, tissue and disease level. We call this the CytoReason Cell-Centered Model, and it is the key to unlocking immune system relational insights that can lead to biological discovery. Our cell-centered approach leverages public and proprietary data, proprietary technologies and methodologies, which when integrated with client data provides disease- and tissue-specific insights that can enhance discovery, shorten trial phases and reduce development costs.


News Articles [5 Associated News Articles listed on BioPortfolio]

Cytoreason’s Unique Immune-Focused AI Model Creates the Largest Library of Inter-Cellular ...

Read more...

Using AI to personalise drug treatments

CytoReason, an immune-focused artificial intelligence technology company generates insights to reveal complex patterns in a variety of biological data

CytoReason Cements Proof-of-Concept with Machine-Learning-Facilitated Biomarker Breakthrough in Anti-TNFα Treatment Failure in Inflammatory Bowel Disease. New Data Published in Gut

CytoReason’s proprietary technology demonstrates ability to reconstruct hidden cellular signals, extrapolate one tissue to another and identify immune system relationships capab...

Cytoreason’s Unique Immune-Focused AI Model Creates the Largest Library of Inter-Cellular Communications - Uses It to Predict 335 Novel Cell-Cytokine Interactions, New Clues for Drug Development

New Data Published by Nature Biotechnology Covering 16,000,000 scientific articles, this massive Natural Language Processing (NLP) project quadruples the reference ...

Unique immune-focused AI model creates largest library of inter-cellular communications

(CytoReason) New data published in Nature Biotech, represents the largest ever analysis of immune cell signaling research, mapping more than 3,000 previously unlisted cellular interactions, and yieldi...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

CytoReason

Born out of 10 years’ research from Stanford and the Technion, CytoReason is the only AI company to focus entirely on the immune system in developing its proprietary data and...

More Information about "CytoReason" on BioPortfolio

We have published hundreds of CytoReason news stories on BioPortfolio along with dozens of CytoReason Clinical Trials and PubMed Articles about CytoReason for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CytoReason Companies in our database. You can also find out about relevant CytoReason Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record